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Background and the purpose of the study: Modafinil, a novel wake-promoting agent with low potential for
abuse and dependence, has a reliable structure to find some novel derivatives with better activity and lower
potential for abuse and risk of dependency. This study was designed to evaluate psychobiological activity of
some novel N-aryl modafinil derivatives.
Methods: Seven novel N-aryl modafinil derivatives were synthesized through three reactions: a) preparation of
benzhydrylsulfanyl acetic acid through reaction of benzhydrol with thioglycolic acid, b) formation of desired amide by
adding the substituted aniline to activated acid with EDC (1-ethyl-3-(3-dimethyl amino propyl) carbodiimide). This
reaction was catalyzed by HOBt (N- hydroxylbenzotriazole), and c) oxidation of sulfur to sulfoxide group with H2O2.
Then, their psychobiological effect on the performance of male albino mice were compared to that of modafinil as
following: wakefulness by determining the effects of derivatives on phenobarbital-induced loss of the righting reflex
(LOPR); exploratory activity by measuring activity in the open field test (OFT); depression by measuring immobility time
(IT) during forced swimming test (FST) and the anxiogenic and anxiolytic like effects by using elevated plus-maze test
(EPM). All tests were videotaped and analyzed for the frequency and duration of the behaviors during the procedures.
Conclusions: 2-(Benzhydrylsulfonyl)-N-(4-chlorophenyl)acetamide (4c) showed comparable result in LOPR test.
However, all analogs were found to be stimulant except 2-(benzhydrylsulfinyl)-N-phenylacetamide (4a). Also 4c led the
most exploratory activity in mice among derivatives. FST results showed that 4a had the longest IT while modafinil,
2-(benzhydrylsulfinyl)-N-(3-chlorophenyl) acetamide (4b) and 2-(benzhydrylsulfinyl)-N-(4-ethylphenyl) acetamide (4d)
had the shortest IT. In EPM, all derivatives showed anxiogenic-like behavior since they decreased open arms time and
open arms entries and simultaneously increased close arms time.
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Narcolepsy is a neurological sleep disorder that is esti-
mated to affect as many as 200,000. It is as widespread
as multiple sclerosis and more prevalent than cystic fi-
brosis, but it is less well known [1,2].
The main treatment of narcolepsy is using of central
nervous system (CNS) stimulants such as amphetamine,
methylphenidate and modafinil which is widely regarded
as the first-line medication for narcolepsy (Figure 1) [1,3].
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reproduction in any medium, provided the orsignificant abuse potential while modafinil which has
lower abuse potential [4,5]. Surprisingly, modafinil is used
sometimes to treat methamphetamine dependency; how-
ever this type of therapy has not been authoritized [6].
In one study, some modafinil analogs were evaluated for
their CNS activity [7]. Most of the derivatives of nitrogen
group like NHCH3, NHCH (CH3)2, HCN (CH3)3 were
stimulant, although some analogs with piperidine or mor-
pholine groups were sedative. Here, synthesis and psycho-
biological evaluation of novel modafinil derivatives with
different N-Aryl moieties were reported. These analogs
with suitable Log P were chosen due to their easy transfer
across the blood brain barrier. The tilted compounds were
prepared according to Scheme 1. The key intermediate 2-
(benzhydrylthio) acetic acid (2) was prepared from benz-
hydrol and thioglycolic acid. Amidation of appropriate. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chemical structure of modafinil.
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responding amide (3a-3g). The obtained amides (3a-3g)




All chemical reagents and solvents used in this study were
purchased from Merck AG (Darmstadt, Germany). Melt-
ing points were determined by Kofler hot stage apparatus
and are not corrected. The IR spectra were obtained on a
Shimadzu 470 spectrophotometer (potassium bromide
disks). NMR spectra were appropriately recorded using aScheme 1 Synthesis of target compounds 4a-4g (R: (a) = H, (b) = 3-Cl,
and conditions: (a) Thioglycolic acid, TFA, 3 h; (b) appropriate amine,Bruker 400 spectrometer (Bruker Bioscience, Billerica,
MA, USA), and chemical shifts were expressed as δ (ppm)
with tetramethylsilane as internal standard. The mass
spectra were run on a Finigan TSQ-70 spectrometer
(Finigan, USA) at 70 eV. Merck silica gel 60 F254 plates
were used for analytical TLC.
Synthesis of 2-(benzhydrylthio)acetic acid (2)
A mixture of benzhydrol (50.0 g, 271.4 mmol) and thio-
glycolic acid (25.0 g, 271.4 mmol) in trifluoroacetic acid
(300 mL) was stirred at room temperature for 3 h. The solv-
ent was removed under reduced pressure to afford a crude
solid. Water (300 ml) was added and the resulting precipitate
collected by filtration. The solid was washed with n-hexane
(400 ml) and dried to afford a white solid (69.2 g).
Yield: 99%, mp: 126–129°C. IR (KBr, cm-1); ῡ: 3071, 2570,
1941, 1860, 1809, 1689, 1596, 1491, 1301, 1203, 1137, 1209,
1021, 804. 1H-NMR (CDCl3, 400 MHz) δ (ppm): 3.1 + .3699
(s, 2H, -SCH2CO-), 5.5 (s, 1H, Ph-CH-Ph), 7.13 (t, J = 7.6 Hz,
aromatic), 7.22-7.25 (m, aromatic), 7.25 (m, aromatic), 7.33
(m, aromatic), 7.45 (m, aromatic) [8].
General procedure for the synthesis of compounds 3a-3g
The mixture of 2-(benzhydrylthio) acetic acid (2), EDC (1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide) (1 mol)
and HOBt (hydroxybenzotriazole) (1 mol) in acetonitrile
solvent was kept under stirring for 30 min in order to acti-
vate acid group. Afterwards, appropriate aniline derivative
was added and the mixture was stirred at room
temperature for 24 h. The solvent was evaporated and(c) = 4-Cl, (d) = 4-Et, (e) = 3,4-Cl, (f) = 4-NO2, (g) = 4-Br), Reagents
EDC, HOBt; (c) appropriate amide, H2O2, acetic acid.
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was washed with sulfuric acid 5%, sodium bicarbonate and
brine. Then, the organic layer was dried over anhydrous
sodium sulfate, filtered and evaporated to dryness. The
residue was chromatographed on silica gel plate eluting
with ethyl acetate/petroleum [9].
2-(benzhydrylthio)-N-phenylacetamide (3a)
Yield: 81%, mp: 90°C. IR (KBr, cm-1); ῡ: 3431, 3243, 3060,
2959, 2854, 1655, 1597, 1547, 1491, 1443, 1325, 754, 696.
1H-NMR (CDCl3, 400 MHz) δ (ppm): 3.26 (s, 2H,
-SCH2CO-), 5.18 (s, 1H, Ph-CH-Ph), 7.13 (t, J = 7.6 Hz, aro-
matic), 7.22-7.25 (m, aromatic), 7.30-7.35 (m, aromatic),
7.41 (d, J = 8 Hz, aromatic), 7.48 (d, J = 8 Hz, aromatic),
8.41 (brs, 1H, NH).
2-(benzhydrylthio)-N-(3-chlorophenyl) acetamide (3b)
Yield: 73%, mp: 60°C. IR (KBr, cm-1); ῡ: 3426, 3329,
3229, 3064, 2923, 1665, 1641, 1593, 1525, 1421, 1310,
1240, 1129, 1074, 878, 775, 698. 1H-NMR (CDCl3, 400
MHz) δ (ppm): 3.27 (s, 2H, -SCH2CO-), 5.18 (s, 1H,
PhCHPh), 7.15 (m, aromatic), 7.25-7.41 (m, aromatic),
8.42 (brs, 1H, NH).
2-(benzhydrylthio)-N-(4-chlorophenyl) acetamide (3c)
Yield: 78%, mp: 90°C. IR (KBr, cm-1); ῡ: 3430, 3121,
3067, 2923, 2853, 1646, 1549, 1490, 1400, 1093, 1034,
823, 700. 1H-NMR (CDCl3, 400 MHz) δ (ppm): 3.27 (s,
2H, -SCH2CO-), 5.15 (s, 1H, PhCHPh), 7.25-7.41 (m,
14H, aromatic), 8.41 (s, 1H, NH).
2-(benzhydrylthio)-N-(4-ethylphenyl) acetamide (3d)
Yield: 72%, mp: 87°C. IR (KBr, cm-1); ῡ: 3258, 3060,
2962, 2925, 2873, 1638, 1599, 1535, 1449, 1410, 1321,
1124, 1073, 1025, 971, 825, 743, 697. 1H-NMR (CDCl3,
400 MHz) δ (ppm): 1.22 (t, 3H, CH3), 2.62 (q, 2H, CH2),
3.25 (s, 2H, -SCH2CO-), 5.19 (s, 1H, PhCHPh), 7.15-7.42
(m, 14H, aromatic), 8.40 (s, 1H, NH).
2-(benzhydrylthio)-N-(3, 4-dichlorophenyl) acetamide (3e)
Yield: 75%, mp: 85°C. IR (KBr, cm-1); ῡ: 3400, 3268,
3087, 2922, 1710, 1650, 1591, 1528, 1480, 1376, 1318,
1118, 1027, 870, 811, 748, 697. 1H-NMR (CDCl3, 400
MHz) δ (ppm): 3.28 (s, 2H, -SCH2CO-), 5.14 (s, 1H,
PhCHPh), 7.65 (s, 1H, H2-Dichlorophenyl) and 7.24-7.40
(m, 12H, aromatic), 8.37 (brs, 1H, NH).
2-(benzhydrylthio)-N-(4-nitrophenyl) acetamide (3f)
Yield: 68%, mp: 80-84°C. IR (KBr, cm-1); ῡ: 3313, 3087,
3017, 2923, 1675, 1616, 1596, 1552, 1500, 1334, 1307,
1255, 1117, 853, 748, 696. 1H-NMR (CDCl3, 400 MHz) δ
(ppm): 3.34 (s, 2H, -SCH2CO-), 5.16 (s, 1H, PhCHPh), 7.24
(d, J = 8Hz, aromatic), 7.31 (t, J = 4Hz, aromatic), 7.4 (d, J =8Hz, aromatic), 7.61 (d, 2H, J = 8Hz, p-Nitrophenyl), 8.19
(d, 2H, J = 8.8Hz, p-Nitrophenyl), 8.64 (brs, 1H, NH).
2-(benzhydrylthio)-N-(4-bromophenyl) acetamide (3g)
Yield: 84%, mp: 92°C. IR (KBr, cm-1); ῡ: 3237, 3027,
2927, 1714, 1641, 1593, 1533, 1490, 1396, 1314, 1125,
1072, 1008, 818, 746, 696. 1H-NMR (CDCl3, 400 MHz) δ
(ppm): 3.28 (s, 2H, -SCH2CO-), 5.17 (s, 1H, PhCHPh),
7.32-7.48 (m, 14H, aromatic), 8.42 (brs, 1H, NH).
General procedure for the synthesis of 2-(benzhydrylsulfinyl)-
N-phenylacetamide (4a-4g)
2-(benzhydrylthio)-N-phenylacetamide (3.46 g, 0.013
mol) was taken in glacial acetic acid (14 ml) with stir-
ring. 1.34 ml of 30% H2O2 was added with chilling in ice
water. The mixture was left in the refrigerator for 4 h
and thereafter worked up by treating with 70 ml of ice-
cold water. The precipitated material was filtered under
suction and washed with ice-cold water to give 1.5 g of
white crystals (43%), mp: 159-160°C [10].
2-(benzhydrylsulfinyl)-N-phenyl acetamide (4a)
Yield: 70%, mp: 98°C. IR (KBr, cm-1); ῡ: 3426, 3056, 2924,
2854, 1673, 1600, 1551, 1493, 1446, 1325, 1112, 1033,
755, 698.
1H-NMR (d ppm, CDCl3, 400 MHz): 3.23 (d, 1H,
-SCH2CO-, J = 12Hz), 3.66 (d, 1H, -SCH2CO-, J = 12Hz),
5.25 (s, 1H, PhCHPh), 7.12 (t, J = 8Hz, aromatic), 7.26 (s,
1H, aromatic), 7.31 (t, J = 8Hz, aromatic), 7.36-7.52 (m,
aromatic), 9.21 (brs, 1H, NH). 13C-NMR (125 MHz,
CDCl3): δ 51.95 (S-CH2), 71.54 (S-CH), 120.15 (C2, 6 anil-
ine), 124.64 (C4 aniline), 128.77 (C3, 5 aniline), 128.87 (C3,5
phenyl), 128.97 (C4 phenyl), 129.51 (C2,6 phenyl), 133.78
(C1 phenyl), 134.29 (C1 aniline), 175.00 (C =O). MS (m/z):
349 (M+), 309, 167, 119, 104, 93, 77, 65, 57, 43.
2-(benzhydrylsulfinyl)-N-(3-chlorophenyl) acetamide (4b)
Yield: 68%, mp: 160°C. IR (KBr, cm-1); ῡ: 3441, 3250,
3184, 3066, 3026, 2923, 2856, 1682, 1596, 1546, 1480,
1430, 1372, 1320, 1035, 794, 700. 1H-NMR (CDCl3, 400
MHz) δ (ppm): 3.23 (d, 1H, -SCH2CO-, J = 12Hz), 3.67 (d,
1H, -SCH2CO-, J = 12Hz), 5.27 (s, 1H, PhCHPh), 7.08-7.50
(m, 13H, aromatic), 7.69 (s, 1H, H2-m-Chlorophenyl), 9.35
(brs, 1H, NH). 13C-NMR (125 MHz, CDCl3): δ 52.34 (S-
CH2), 71.38 (S-CH), 117.88 (C3 aniline), 120.04 (C2 anil-
ine), 124.55 (C4 aniline), 128.84 (C3, 5 phenyl), 128.90 (C4
phenyl), 128.99 (C2,6 phenyl), 129.51 (C6 aniline), 131.94
(C5 aniline), 133.67 (C1 phenyl), 134.37 (C1 aniline), 162.16
(C = O). MS (m/z): 385 (M++2), 383 (M+), 293, 201, 167,
153, 127, 111, 91, 64, 47.
2-(benzhydrylsulfinyl)-N-(4-chlorophenyl) acetamide (4c)
Yield: 73%, mp: 170°C. IR (KBr, cm-1); ῡ: 3444, 3248, 2920,
1684, 1597, 1541, 1489, 1398, 1320, 1246, 1037, 743, 701.
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-SCH2CO-, J = 16Hz), 3.66 (d, 1H, -SCH2CO-, J = 16Hz),
5.26 (s, 1H, PhCHPh), 7.24 (d, 2H, J = 8Hz, p-Chlorophenyl),
725–7.50 (m, 12H, aromatic), 9.33 (brs, 1H, NH). 13C-NMR
(125 MHz, CDCl3): δ 52.21 (S-CH2), 71.52 (S-CH), 121.19
(C-Cl), 128.85 (C2, 6 aniline), 128.91 (C3,5 phenyl), 128.98
(C4 phenyl), 129.52 (C2,6 phenyl), 129.56 (C3,5 aniline),
134.29 (C1 phenyl), 136.18 (C1 aniline), 162.08 (C =O). MS
(m/z): 385 (M++2), 383 (M+), 167, 153, 127, 111.
2-(benzhydrylsulfinyl)-N-(4-ethylphenyl) acetamide (4d)
Yield: 74%, mp: 158°C. IR (KBr, cm-1) ῡ: 3253, 3185, 3058,
2957, 2923, 2858, 1679, 1540, 1412, 1322, 1043, 957, 832,
747, 701.
1H NMR (CDCl3, 400 MHz) δ (ppm): 1.23 (t, 3H, CH3),
2.63 (q, 2H, CH2), 3.23 (d, 1H, J = 12Hz, -SCH2CO-), 3.66
(d, 1H, -SCH2CO-, J = 12Hz), 5.21 (s, 1H, PhCHPh), 7.16-
7.48 (m, 14H, aromatic), 9.21 (brs, 1H, NH). 13C-NMR
(125 MHz, CDCl3): δ 15.66 (CH3), 28.33 (CH2), 36.97 (S-
CH2), 55.09 (S-CH), 120.22 (C4 aniline), 127.53 (C2, 6 anil-
ine), 128.25 (C3,5 phenyl), 128.34 (C4 phenyl), 128.46 (C2,6
phenyl), 128.84 (C3,5 aniline), 135.02 (C1 phenyl), 140.10
(C1 aniline), 166.28 (C =O). MS (m/z): 377 (M
+), 284, 279,
191, 167, 149, 105, 85, 71, 57.
2-(benzhydrylsulfinyl)-N-(3, 4-dichlorophenyl) acetamide (4e)
Yield: 63%, mp: 140°C. IR (KBr, cm-1); ῡ: 3293, 3258,
3101, 3052, 2912, 1711, 1686, 1587, 1383, 1312, 1224,
1146, 1036, 878, 820, 742, 698. 1H NMR (CDCl3, 400
MHz) δ (ppm): 3.24 (d, 1H, J =16Hz, -SCH2CO-), 3.67
(d, 1H, J = 16Hz, -SCH2CO-), 5.32 (s, 1H, PhCHPh),
7.23-7.48 (m, 12H, aromatic), 7.77 (s, 1H, H2-m-Chloro-
phenyl), 9.45 (brs, 1H, NH). 13C-NMR (125 MHz,
CDCl3): δ 52.13 (S-CH2), 71.41 (S-CH), 118.99 (C4 anil-
ine), 121.48 (C2 aniline), 121.56 (C6 aniline), 128.87 (C3,5
phenyl), 129.04 (C4 phenyl), 129.50 (C2, 6 phenyl), 129.56
(C3 aniline), 131.94 (C5 aniline), 133.64 (C1 phenyl),
134.19 (C1 aniline), 162.14 (C = O). MS (m/z): 421 (M
+4),
419 (M++2), 417 (M+), 199, 184, 167, 149, 105.
2-(benzhydrylsulfinyl)-N-(4-nitrophenyl) acetamide (4f)
Yield: 76%, mp: 198°C. IR (KBr, cm-1); ῡ: 3448, 3202,
3078, 2922, 2852, 1702, 1618, 1598, 1566, 1497, 1335,
1251, 1159, 1039, 859, 748, 698. 1H NMR (CDCl3, 400
MHz) δ (ppm): 3.47 (d, 1H, -SCH2CO-, J = 12Hz), 3.76
(d, 1H, -SCH2CO-, J = 12Hz), 5.42 (s, 1H, PhCHPh),
7.35-7.41 (m, 8H, aromatic), 7.53 (d, 2H, J = 8.4Hz, aro-
matic), 7.78(d, 2H, J = 8Hz, p-Nitrophenyl), 8.16 (d, 2H,
J = 8Hz, p-Nitrophenyl), 10.40 (brs, 1H, NH). MS (m/z):
394 (M+), 279, 257, 236, 167, 149, 69, 57, 43.
2-(benzhydrylsulfinyl)-N-(4-bromophenyl) acetamide (4g)
Yield: 66%, mp: 155°C. IR (KBr, cm-1); ῡ: 3430, 2923,
2853, 1741, 1663, 1630, 1454, 1379, 1240, 1155, 1034,837, 743, 700. 1H NMR (CDCl3, 400 MHz) δ (ppm): 3.24
(d, 1H, -SCH2CO-, J = 16Hz), 3.65 (d, 1H, -SCH2CO-, J =
16Hz), 5.33 (s, 1H, PhCHPh), 7.26-7.49 (m, 14H, aromatic),
9.44 (s, 1H, NH). 13C-NMR (125 MHz, CDCl3): δ 51.68 (S-
CH2), 71.76 (S-CH), 117.24 (C-Br), 121.82 (C2, 6 aniline),
128.82 (C3,5 phenyl), 129.00 (C4 phenyl), 129.43 (C2, 6
phenyl), 129.55 (C3, 5 aniline), 131.94 (C1 phenyl), 136.61
(C1 aniline), 162.19 (C = O). MS (m/z): 429 (M
++2), 428
(M++1), 368, 362, 167, 152, 69, 57, 43.
Psychobiological activity
Animals
This study approved by the Laboratory Animal Care
Committee of School of Veterinary Medicine, Razi Univer-
sity, Kermanshah, Iran. The experiments were carried out
on male albino mice weighing 20–25 g at the beginning of
the experiments. The animals were maintained under
standard laboratory conditions (12-h light/dark cycle,
room temperature 21 ± 1°C) with free access to tap water
and laboratory chow (Dan-e-pars Co., Kermanshah, Iran)
except during brief periods of experiments, and were
adapted to the laboratory conditions for at least 1 week.
Each experimental group consisted of 5–6 animals.
Drugs
The compounds tested were: modafinil (Modiodal®,
Cephalon, France), Phenobarbital (Chemi darou product,
Iran) and our made modafinil derivatives. All agents
were diluted to an adequate concentration using di-
methyl sulfoxide (DMSO). They were administered in-
traperitoneally (i.p.) 30 min prior to each behavioral test.
Control groups received DMSO injection at the same
volume and by the same route. The doses of modafinil
and its derivatives (100 mg/kg) employed in the present
study was adopted from previous study [11]. The dose of
phenobarbital (50 mg/kg) was chosen according to that
commonly used dose reported in the literature [12]. In
all tests, each mouse was tested once.
Phenobarbital-induced loss of righting reflex
Phenobarbital (50 mg/kg i.p.) was administered to each
mouse. The loss of righting reflex (LORR) was measured
as the time interval between losing and recovery of the
righting reflex after phenobarbital administration. Recov-
ery of the righting reflex was defined as the ability of the
animal to return to its feet 3 times within 60 sec when
placed on its back [13]. Mice received modafinil or its de-
rivatives (100 mg/kg, i.p.) 30 min before i.p. injection of
phenobarbital. The ethological room was illuminated with
a soft light and external noise was attenuated.
Open field test (OFT)
The open field consisted of a square arena (60 × 60 cm2),
with a white floor divided into 36 squares (10 × 10 cm2),
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The test was initiated by placing a single mouse in the
middle of the arena and letting him move freely for 5
min. The mice had not been pre-exposed to the arena.
Mouse behavior was continuously videotaped by a video
camera placed over the apparatus and the arena was
carefully cleaned with alcohol and rinsed with water
after every test to eliminate olfactory cues. Decrease of
the latency to enter the central part was considered as
an indicator of anxiolysis and locomotor activity was
evaluated by counting the number of segments crossed
with a 4-paw as described previously [14].
Forced swimming test (FST)
Mice were individually forced to swim in a plastic cylinder
(25 × 25 × 40 cm3) containing 18 cm of water at 22°C.
This volume of water precluded mice touching the bottom
with their feet or tails. Mice were submitted to the proced-
ure for 15 min on the first day (pretest) and for 5 min on
the second day test, 24 h later. Each mouse i.p. received
the tested derivatives 30 min before forced swimming
paradigm. At the end of the swimming exposition, the ani-
mals were removed from the water and gently dried. The
initial 5 min of both swimming sessions were videotaped
for behavioral analysis. The immobility time (IT) was re-
corded only during the last 4 min of these periods, and
was defined as the sum of time that the animal was float-
ing, with the face above the water surface and making only
slight movements with the front paws to keep from sub-
merging as described previously [15]. The frequency of al-
ternation between mobility and immobility behaviors
gradually decreased as time lapsed, the animals tending to
remain much more immobile. The decrease and increase
of immobility time were interpreted as antidepressive or
depressive actions, respectively [16].
Elevated plus maze (EPM)
Behavioral effect of modafinil and its derivatives were ele-
vated in the mouse EPM paradigm. The experimental ap-
paratus is shaped like a “plus” sign and consists of a
central platform (5 × 5 cm), two open arms (30 × 15 × 5
cm) and two equal-sized closed arms opposite to each
other. The maze is made of wood, elevated to a height of
50 cm above the floor. A video camera was mounted verti-
cally about 1meter above the plus-maze for recording be-
havioral responses. The test consisted of placing a mouse
in the central platform facing an enclosed arm and
allowed it to freely explore the maze for 5 min. Entry into
one arm was defined as the animal placing all four paws
into that arm. The test arena was wiped with a damp cloth
after each trial. The number of entries into the open and
closed arms and the time spent in open arms were mea-
sured in the offline condition. Anxiolytic activity was indi-
cated with increase of time spent in open arms or withnumber of open arms entries while anxiogenic effects are
characterized with decrease of these measures.
For the purpose of analysis, open-arm activity was quan-
tified as the amount of time that the rat spent in the open
arms relative to the total amount of time spent in open
arm (open/total × 100), and the number of entries into the
open arms was quantified relative to the total number of
entries into open arm (open/total × 100) [17].
Statistics
The data are expressed as mean ± S.E.M. The statistical
analyses were performed using one-way analyses of vari-
ance (ANOVA). Post-hoc comparison of means was car-
ried out with the Tukey's test for multiple comparisons,
when appropriate. All data were analyzed using the Gen-
eral Linear Models Procedure of SPSS ver.16 (SPSS Inc.,
Chicago, IL, USA). The confidence limit of P <0.05 was
considered as statistically significant.
Results and discussion
Chemistry
Our synthetic route to target compounds 4a-4g (Table 1)
is shown in Scheme 1. The key intermediate 2-(benzhy-
drylthio) acetic acid 2 was prepared from benzhydrol
and thioglycolic acid in trifluoroacetic acid (TFA). 1-
Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
was treated with 2-(benzhydrylthio) acetic acid 2 in the
presence of hydroxybenzotriazole (HOBt) and stirred for
30 min in acetonitrile. Then, appropriate amine deriva-
tive was added and stirring was continued overnight.
Thereafter the mixture was washed sequentially with %5
NaHCO3 and saturated NaCl solutions, and then dried
over Na2SO4. Removal of the solvent under reduced
pressure afforded the amide derivatives 3a-3g. The ob-
tained amide derivatives 3a-3g were gently oxidized by
H2O2 to form the corresponding sulfoxide derivatives
4a-4g (Table 1) and analyzed by 1H NMR, infrared, mass
spectroscopy and melting point.
1H NMR spectrum of intermediate 2 showed the ben-
zylic hydrogen was more deshielded (5.50 ppm) than
benzylic hydrogen of benzhydrol. Based on 1H NMR
analysis of intermediates 3a-3g, the corresponding sig-
nals of protons CH benzylic, methylene group adjacent
to carbonyl substituent, and NH were appeared within
5.0-5.2 ppm as a singlet, 3.2-3.5 ppm as a singlet, 8.40-
8.65 ppm as a broad singlet respectively. Broad singlet
peak of the NH proton is a good sign for formation of
the amidic bond in this series. The aromatic hydrogens
of the phenyl rings are generally appeared in the range
between 7.0-8.0 ppm. The 1H NMR spectra of com-
pounds 4a-4g corresponding to the methylene group be-
tween carbonyl and sulfoxide substituents showed a
doublet of doublet splitting pattern. This behavior is due
to existence of two diastereotopic hydrogens of the
Figure 2 Exploratory activity (mean ± S.E.M.) in albino mice in
the open field test. aP < 0.05, aaP < .001 vs. control and bP < 0.05,
bbP < 0.001 vs. modafinil groups.
Table 1 Effects of N-aryl derivatives of modafinil on behavior of albino mice in the elevated plus-maze
Compound Open arms entries (O.E) Open arms time spend (O.T) Close arms entries (C.E) Close arms time spend (C.T)
Modafinil 8.25(2.17) 71.7(10.5) 11.75(3.88) 228.2(10.5)
4a 1.00(1.00)a 1.5(1.5)aab 8.00(3.82) 221.2(23.8)aa
4b 7.25(1.25) 84.5(19.3) 6.25(0.47) 215.5(19.3)
4c 0.00(0.00)aab 0.0(0.0)aab 2.00(0.00) 285.0(6.4)aa
4d 3.50(1.50) 57.5(17.5) 4.50(1.50) 242.5(17.5)
4e 0.00(0.00)a 0.0(0.0)aa 1.50(0.50) 300.0(0.0)aa
4f 6.00(1.00) 120.0(10.0) 6.50(1.50) 180.0(10.0)
4g 2.50(1.190) a 16.75(10.0)aa 8.25(2.59) 216.2(26.7)aa
Control 12.25(2.86) 123.5(19.5) 10.50(3.92) 175.5(19.1)
Data are presented as mean ± S.E.M.
aP < 0.05 vs. control group, aaP < 0.001 vs. control group, bP < 0.05 vs. modafinil group.
Lari et al. DARU Journal of Pharmaceutical Sciences 2013, 21:67 Page 6 of 8
http://www.darujps.com/content/21/1/67methylene group. In addition, mass spectrometry ana-
lysis of the synthesized compounds 4a-4g showed ex-
pectable fragmentation and hence established the
structure of modafinil derivatives. Potassium bromide
(KBr) disk was used to obtain the infra red (IR)
spectrum related to each compound. The peak related to
the carbonyl group appeared in <1700 cm-1 is a sign of
the amidic carbonyl group in IR spectrum and it is a




For comparability of data, we had to use same doses of
derivatives. Based on previous study [10], 100 mg/kg of
modafinil could be a suitable dose. In this dose, some
analogs like 4c made mice subconscious after i.p. admin-
istration of phenobarbital. On the other hand, some
mice which received compound 4a, died. This may be
due to more sedative activity of this analog.
In comparison with control animals, compound 4a
significantly increased phenobarbital-induced LORR
while other compounds demonstrated a decrease in the
duration of LORR.
The experiment showed that compound 4c was the
best CNS stimulant among our synthetic derivatives
however it was a slightly weaker than modafinil. Stimu-
lant activity of used compounds is ranged in the follow-
ing order:
Modafinil > 4c > 4g > 4d > 4f > 4b > 4e > DMSO (con-
trol) > 4a
OFT
The results of the duration of active exploration in the
OFT are presented in Figure 2. Mean square crossing of
compound 4c, 4d and 4f did not show significant differ-
ences when compared to the respective control and
modafinil groups. Compound 4a, 4b and 4g were recog-
nized to significantly reduce square crossing comparedto control (4a, 4g: p < 0.05, 4b: p < 0.001). Furthermore,
the square crossing of compounds 4a, 4b, 4e and 4g
were significantly decreased compared to modafinil (4a,
4b and 4g: P < 0.001, #5: P < 0.05, respectively).
The results in Figure 3 showed that all compounds ex-
cept compound 4f failed to reach the statistically signifi-
cant level in measuring the latency to enter the central
part compared to control and modafinil groups. Com-
pound 4f showed had a reliable decrease in the latency
to enter the central part compared to the both groups
(P < 0.05).
FST
The effects of derivatives and modafinil on IT during tri-
als were depicted in Figure 4. The control animals
showed 45 ± 3 sec immobility duration during FST.
Compounds 4a and 4e increased IT and showed consid-
erable differences when compared to the respective con-
trol groups (P < 0.001). Compound 4g also lengthened
IT in comparison to control (P < 0.05). In addition,
Figure 3 Effects of different derivatives in open field test in
mice. Data are expressed as mean ± SEM of the latency to enter the
central part. aP < 0.05 vs. control, bP < 0.05 vs. modafinil.
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increase in IT compared to modafinil group (P < 0.001).
The rest of the compounds significantly decreased IT
in comparison to control (P < 0.001).
EPM
Mice exposed to compounds 4a, 4c, 4e and 4g showed
decline in open arms entries and open arms spent time
in comparison to control mice (P < 0.05). However, mod-
afinil, compounds 4b, 4d and control (DMSO) showed
similar results (P > 0.05). (See Table 1.)
The percent of close arms entries revealed that all de-
rivatives showed a non-significantly decrease in this par-
ameter compared to those of control and modafinil
groups.Figure 4 Effect of different derivatives of modafinil on the
immobility response in forced swimming test (aP < .05,
aaP < .001 vs. control and bbP < 0.001 vs. modafinil groups).Compound 4a, 4c, 4e and 4g produced a reliable in-
crease of close time spend (P < 0.05) than control group.
Conclusions
We have described a novel series of modafinil analogs
(4a-4g) that displayed some kind of CNS activities. From
our psychobiological results, compounds 4a, 4c, 4e and
4g decreased frequencies of open arms entries and dur-
ation of open arms spent times, suggesting an
anxiogenic-like effect and as well as these derivatives in-
creased close arms time significantly. Compounds 4a, 4e
and 4g also lengthened IT in FST, indicating that the de-
rivatives exerted a depressive action, while other deriva-
tives shortened IT and would be considered to have
antidepressant effects. The square crossing numbers of
compounds 4a, 4b and 4g showed a significant reduc-
tion compared to modafinil and control groups which
suggest this compound may be putative sedative. Com-
pound 4f induced an anxiolytic-like effect because it de-
creased the latency to enter the central part compared
to other derivatives. The results of EPM also roughly
confirmed the anxiolytic-like effect of compound 4f.
Based on LORR test, it is evident that most of the ana-
logs exhibited stimulant activity in LORR test and com-
pound 4c is the most potent ones. Only compound 4a
(aniline substitution) was recognized as sedative analog.
Finally, little discrepancies among results obtained from
different psychobiological tests in this study may be re-
lated to the different mechanisms of actions of these de-
rivatives and future studies are highly requested to
exploit the structure-function relationships of these de-
rivatives in more details.
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